Toll Free: 1-888-928-9744

Bausch & Lomb Incorporated - Product Pipeline Review - 2014

Published: Apr, 2014 | Pages: 37 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Bausch & Lomb Incorporated - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Bausch & Lomb Incorporated - Product Pipeline Review - 2014', provides an overview of the Bausch & Lomb Incorporated's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Bausch & Lomb Incorporated's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Bausch & Lomb Incorporated including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Bausch & Lomb Incorporated's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Bausch & Lomb Incorporated's pipeline products

Reasons to buy

- Evaluate Bausch & Lomb Incorporated's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Bausch & Lomb Incorporated in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Bausch & Lomb Incorporated's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Bausch & Lomb Incorporated and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Bausch & Lomb Incorporated
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Bausch & Lomb Incorporated and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Bausch & Lomb Incorporated Snapshot 5
Bausch & Lomb Incorporated Overview 5
Key Information 5
Key Facts 5
Bausch & Lomb Incorporated - Research and Development Overview 6
Key Therapeutic Areas 6
Bausch & Lomb Incorporated - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Bausch & Lomb Incorporated - Pipeline Products Glance 12
Bausch & Lomb Incorporated - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Bausch & Lomb Incorporated - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Bausch & Lomb Incorporated - Drug Profiles 15
brimonidine tartrate 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
latanoprostene bunod 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
mapracorat 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
bepotastine besylate 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Bausch & Lomb Incorporated - Pipeline Analysis 23
Bausch & Lomb Incorporated - Pipeline Products by Target 23
Bausch & Lomb Incorporated - Pipeline Products by Route of Administration 24
Bausch & Lomb Incorporated - Pipeline Products by Molecule Type 25
Bausch & Lomb Incorporated - Pipeline Products by Mechanism of Action 26
Bausch & Lomb Incorporated - Recent Pipeline Updates 27
Bausch & Lomb Incorporated - Dormant Projects 31
Bausch & Lomb Incorporated - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Bausch & Lomb Incorporated - Key Manufacturing Facilities 35
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 37
Disclaimer 37
List of Tables
Bausch & Lomb Incorporated, Key Information 5
Bausch & Lomb Incorporated, Key Facts 5
Bausch & Lomb Incorporated - Pipeline by Indication, 2014 7
Bausch & Lomb Incorporated - Pipeline by Stage of Development, 2014 8
Bausch & Lomb Incorporated - Monotherapy Products in Pipeline, 2014 9
Bausch & Lomb Incorporated - Partnered Products in Pipeline, 2014 10
Bausch & Lomb Incorporated - Partnered Products/ Combination Treatment Modalities, 2014 11
Bausch & Lomb Incorporated - Phase III, 2014 12
Bausch & Lomb Incorporated - Phase II, 2014 13
Bausch & Lomb Incorporated - Phase I, 2014 14
Bausch & Lomb Incorporated - Pipeline by Target, 2014 23
Bausch & Lomb Incorporated - Pipeline by Route of Administration, 2014 24
Bausch & Lomb Incorporated - Pipeline by Molecule Type, 2014 25
Bausch & Lomb Incorporated - Pipeline Products by Mechanism of Action, 2014 26
Bausch & Lomb Incorporated - Recent Pipeline Updates, 2014 27
Bausch & Lomb Incorporated - Dormant Developmental Projects,2014 31
Bausch & Lomb Incorporated, Other Locations 32
Bausch & Lomb Incorporated, Subsidiaries 32
Bausch & Lomb Incorporated, Key Manufacturing Facilities 35 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify